Cite
HARVARD Citation
Chi, C. et al. (2022). Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations. Therapeutic advances in medical oncology. p. . [Online].